CD4 and melanoma: Additionally, the combination of BRAF and MEK inhibitors was reported to induce GSDME-dependent pyroptosis through caspase-3 and the release of pro-inflammatory factors in melanoma cells, which is associated with an increase in CD4+ T cell and CD8+ T cell infiltration and decreased TAM levels.